Sai Life Sciences Limited has successfully commenced commercial operation of the second phase of the production block with ≈91 kL of capacity at its facility in Bidar, Karnataka, India.

This is the second and final phase of the overall capacity addition of ≈195 kL which was under construction at Unit IV Bidar Facility as disclosed in the prospectus. Accordingly, the combined capacity of Unit IV Bidar Facility will be ≈640 kL which will be equipped to supply Registered Starting Materials ("RSM"), intermediates, and Active Pharmaceutical Ingredients (APIs) for both clinical and commercial purposes.